172 related articles for article (PubMed ID: 37734579)
1. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy.
Zou J
Environ Res; 2023 Dec; 238(Pt 1):117111. PubMed ID: 37734579
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Combined Thermosensitive Gel Co-Loaded with Dermaseptin-PP and PTX Liposomes for Effective Local Chemotherapy.
Dong Z; Zhang Q; Wang C; Hu W; Yu X; Guo M; Zhang X; Sun M; Du S; Lu Y
Int J Nanomedicine; 2023; 18():413-424. PubMed ID: 36711004
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
5. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.
Hong C; Wang D; Liang J; Guo Y; Zhu Y; Xia J; Qin J; Zhan H; Wang J
Theranostics; 2019; 9(15):4437-4449. PubMed ID: 31285771
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
[TBL] [Abstract][Full Text] [Related]
7. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
8. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
9. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
Ezhilarasan D; Lakshmi T; Mallineni SK
Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
[TBL] [Abstract][Full Text] [Related]
11. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.
Patil YB; Swaminathan SK; Sadhukha T; Ma L; Panyam J
Biomaterials; 2010 Jan; 31(2):358-65. PubMed ID: 19800114
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments.
Wan X; Beaudoin JJ; Vinod N; Min Y; Makita N; Bludau H; Jordan R; Wang A; Sokolsky M; Kabanov AV
Biomaterials; 2019 Feb; 192():1-14. PubMed ID: 30415101
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
14. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Cai L; Xu G; Shi C; Guo D; Wang X; Luo J
Biomaterials; 2015 Jan; 37():456-468. PubMed ID: 25453973
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
16. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
17. TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.
Jiang G; Wang X; Zhou Y; Zou C; Wang L; Wang W; Zhang D; Xu H; Li J; Li F; Luo D; Ma X; Ma D; Tan S; Wei R; Xi L
Int J Nanomedicine; 2021; 16():4087-4104. PubMed ID: 34163161
[TBL] [Abstract][Full Text] [Related]
18. Calcium Orthophosphate in Liposomes for Co-Delivery of Doxorubicin Hydrochloride/Paclitaxel in Breast Cancer.
Chen X; He H; Guo X; Hou M; Zhang X; Li S; Wang C; Zhao G; Li W; Zhang X; Hong W
Mol Pharm; 2023 Aug; 20(8):3914-3924. PubMed ID: 37384449
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
20. Liposomes: An Emerging Approach for the Treatment of Cancer.
Mishra K; Jain AK
Curr Pharm Des; 2021; 27(20):2398-2414. PubMed ID: 33823772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
